WO1999026918A1 - Derives de biphenylamidine - Google Patents
Derives de biphenylamidine Download PDFInfo
- Publication number
- WO1999026918A1 WO1999026918A1 PCT/JP1998/005209 JP9805209W WO9926918A1 WO 1999026918 A1 WO1999026918 A1 WO 1999026918A1 JP 9805209 W JP9805209 W JP 9805209W WO 9926918 A1 WO9926918 A1 WO 9926918A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- group
- atom
- alkyl
- formula
- hydroxyl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D207/08—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon radicals, substituted by hetero atoms, attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C251/00—Compounds containing nitrogen atoms doubly-bound to a carbon skeleton
- C07C251/02—Compounds containing nitrogen atoms doubly-bound to a carbon skeleton containing imino groups
- C07C251/18—Compounds containing nitrogen atoms doubly-bound to a carbon skeleton containing imino groups having carbon atoms of imino groups bound to carbon atoms of rings other than six-membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C257/00—Compounds containing carboxyl groups, the doubly-bound oxygen atom of a carboxyl group being replaced by a doubly-bound nitrogen atom, this nitrogen atom not being further bound to an oxygen atom, e.g. imino-ethers, amidines
- C07C257/10—Compounds containing carboxyl groups, the doubly-bound oxygen atom of a carboxyl group being replaced by a doubly-bound nitrogen atom, this nitrogen atom not being further bound to an oxygen atom, e.g. imino-ethers, amidines with replacement of the other oxygen atom of the carboxyl group by nitrogen atoms, e.g. amidines
- C07C257/18—Compounds containing carboxyl groups, the doubly-bound oxygen atom of a carboxyl group being replaced by a doubly-bound nitrogen atom, this nitrogen atom not being further bound to an oxygen atom, e.g. imino-ethers, amidines with replacement of the other oxygen atom of the carboxyl group by nitrogen atoms, e.g. amidines having carbon atoms of amidino groups bound to carbon atoms of six-membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D207/08—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon radicals, substituted by hetero atoms, attached to ring carbon atoms
- C07D207/09—Radicals substituted by nitrogen atoms, not forming part of a nitro radical
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/16—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D211/20—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms
- C07D211/22—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms by oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D211/26—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D211/26—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by nitrogen atoms
- C07D211/28—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by nitrogen atoms to which a second hetero atom is attached
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/40—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/60—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D211/62—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals attached in position 4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
- C07C2601/14—The ring being saturated
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Life Sciences & Earth Sciences (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Description
Claims
Priority Applications (19)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU11740/99A AU744567B2 (en) | 1997-11-20 | 1998-11-19 | Biphenylamidine derivatives |
DK98954747T DK1043310T3 (da) | 1997-11-20 | 1998-11-19 | Biphenylamidinderivater |
BR9814983-0A BR9814983A (pt) | 1997-11-20 | 1998-11-19 | Derivado de bifenil-amidina, pró-medicamento; inibidor de coagulação sanguìnea, e, agentes profilático e terapêutico para trombose ou êmbolo. |
SK761-2000A SK7612000A3 (en) | 1997-11-20 | 1998-11-19 | Biphenylamidine derivatives |
UA2000063535A UA52797C2 (uk) | 1997-11-20 | 1998-11-19 | Похідне біфеніламідину, проліки, інгібітор коагуляції крові, агент для профілактики тромбозу або емболії та агент для терапії тромбозу або емболії |
EP98954747A EP1043310B1 (en) | 1997-11-20 | 1998-11-19 | Biphenylamidine derivatives |
DE69824450T DE69824450T2 (de) | 1997-11-20 | 1998-11-19 | Biphenylamidin-derivate |
NZ504407A NZ504407A (en) | 1997-11-20 | 1998-11-19 | Biphenylamidine derivatives substituted by nitrogen containing heterocyclic ring useful as a Factor Xa inhibitor |
AT98954747T ATE268751T1 (de) | 1997-11-20 | 1998-11-19 | Biphenylamidin-derivate |
CA002310331A CA2310331A1 (en) | 1997-11-20 | 1998-11-19 | Biphenylamidine derivatives |
HU0100085A HUP0100085A3 (en) | 1997-11-20 | 1998-11-19 | Biphenylamidine derivatives and pharmaceutical compositions containing them |
IL13610098A IL136100A (en) | 1997-11-20 | 1998-11-19 | Biphenylamidine derivatives and pharmaceutical compositions containing the same |
US09/554,799 US6706745B1 (en) | 1997-11-20 | 1998-11-19 | Biphenylamidine derivatives |
KR1020007005463A KR100581506B1 (ko) | 1997-11-20 | 1998-11-19 | 비페닐아미딘 유도체 |
EEP200000298A EE04564B1 (et) | 1997-11-20 | 1998-11-19 | Bifenlamidiini derivaadid, eelravim, vere koagulatsiooniinhibiitor ning proflaktiline ja terapeutiline toimeaine tromboosi v?i emboolia vastu |
IS5497A IS5497A (is) | 1997-11-20 | 2000-05-15 | Bífenýlamidínafleiður |
HR20000304A HRP20000304B1 (en) | 1997-11-20 | 2000-05-16 | Biphenylamidine derivatives |
BG104447A BG63536B1 (bg) | 1997-11-20 | 2000-05-17 | Бифениламидинови производни |
NO20002589A NO20002589L (no) | 1997-11-20 | 2000-05-19 | Bifenylamidinderivater |
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP9/319698 | 1997-11-20 | ||
JP31969897 | 1997-11-20 | ||
JP12749898 | 1998-05-11 | ||
JP10/127498 | 1998-05-11 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO1999026918A1 true WO1999026918A1 (fr) | 1999-06-03 |
Family
ID=26463455
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/JP1998/005209 WO1999026918A1 (fr) | 1997-11-20 | 1998-11-19 | Derives de biphenylamidine |
Country Status (28)
Country | Link |
---|---|
US (1) | US6706745B1 (ja) |
EP (1) | EP1043310B1 (ja) |
KR (1) | KR100581506B1 (ja) |
CN (1) | CN1150162C (ja) |
AT (1) | ATE268751T1 (ja) |
AU (1) | AU744567B2 (ja) |
BG (1) | BG63536B1 (ja) |
BR (1) | BR9814983A (ja) |
CA (1) | CA2310331A1 (ja) |
DE (1) | DE69824450T2 (ja) |
DK (1) | DK1043310T3 (ja) |
EE (1) | EE04564B1 (ja) |
ES (1) | ES2218866T3 (ja) |
HR (1) | HRP20000304B1 (ja) |
HU (1) | HUP0100085A3 (ja) |
ID (1) | ID24846A (ja) |
IL (1) | IL136100A (ja) |
IS (1) | IS5497A (ja) |
NO (1) | NO20002589L (ja) |
NZ (1) | NZ504407A (ja) |
PL (1) | PL340658A1 (ja) |
PT (1) | PT1043310E (ja) |
RU (1) | RU2197478C2 (ja) |
SK (1) | SK7612000A3 (ja) |
TR (1) | TR200001452T2 (ja) |
TW (1) | TW523504B (ja) |
UA (1) | UA52797C2 (ja) |
WO (1) | WO1999026918A1 (ja) |
Cited By (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2000044380A1 (fr) * | 1999-01-28 | 2000-08-03 | Teijin Limited | Preparations regulatrices de liberation |
WO2000069811A1 (fr) * | 1999-05-17 | 2000-11-23 | Teijin Limited | Derives de cyanobiphenyle |
EP1043311A4 (en) * | 1997-11-20 | 2001-01-24 | Teijin Ltd | BIPHENYLAMIDINE DERIVATIVES |
WO2001056989A2 (en) * | 2000-02-01 | 2001-08-09 | Cor Therapeutics, Inc. | Inhibitors of factor xa |
US6949668B2 (en) | 2001-11-30 | 2005-09-27 | Teijin Limited | Process for producing 5-(3-cyanophenyl)-3-formylbenzoic acid compound |
WO2007021032A1 (ja) | 2005-08-18 | 2007-02-22 | Teijin Pharma Limited | 正確な用量分割機能を有する製剤 |
WO2007021033A1 (ja) | 2005-08-18 | 2007-02-22 | Teijin Pharma Limited | 複数の薬物保持部位がある錠剤 |
WO2007055427A1 (en) | 2005-11-14 | 2007-05-18 | Teijin Pharma Limited | Intraorally rapidly disintegrating tablet |
EP2982668A2 (en) | 2002-12-03 | 2016-02-10 | Pharmacyclics LLC | 2-(2-hydroxybiphenyl-3-yl)-1h-benzoimidazole-5-carboxamidine derivatives as factor viia inhibitors for the treatment of thromboembolic disorders |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6316475B1 (en) * | 2000-11-17 | 2001-11-13 | Abbott Laboratories | Aminoalkoxybiphenylcarboxamides as histamine-3 receptor ligands and their therapeutic applications |
EP1361213A4 (en) * | 2001-01-26 | 2004-06-09 | Teijin Ltd | METHOD FOR THE PRODUCTION OF CYANOPHENYLBENEOIC ACID DERIVATIVES |
CN1489575A (zh) * | 2001-01-29 | 2004-04-14 | ������������ʽ���� | 苯甲脒衍生物及其制备方法 |
AR035425A1 (es) * | 2001-01-30 | 2004-05-26 | Teijin Ltd | Cristal de diclorhidrato del acido 3-(3-amidinofenil)-5-[({[1-(iminoetil)-4-piperidil]metil}amino)metil]benzoico y proceso para prepararlo |
JPWO2002060448A1 (ja) * | 2001-01-30 | 2004-05-27 | 帝人株式会社 | 医薬組成物 |
JPWO2003040086A1 (ja) * | 2001-11-09 | 2005-03-03 | キッセイ薬品工業株式会社 | 5−アミジノ−2−ヒドロキシベンゼンスルホンアミド誘導体、それを含有する医薬組成物、その医薬用途およびその製造中間体 |
WO2016198691A1 (en) | 2015-06-11 | 2016-12-15 | Basilea Pharmaceutica Ag | Efflux-pump inhibitors and therapeutic uses thereof |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH04334351A (ja) * | 1991-01-24 | 1992-11-20 | Dr Karl Thomae Gmbh | ビフェニル誘導体、これらの化合物を含む製薬組成物及びそれらの調製法 |
JPH0650977A (ja) * | 1992-04-28 | 1994-02-25 | Dr Karl Thomae Gmbh | 標識フィブリノーゲンレセプター拮抗物質、その使用及びそれらの調製法 |
JPH101467A (ja) * | 1996-06-13 | 1998-01-06 | Banyu Pharmaceut Co Ltd | ビフェニルアミジン誘導体 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE4219158A1 (de) * | 1992-06-11 | 1993-12-16 | Thomae Gmbh Dr K | Biphenylderivate, diese Verbindungen enthaltende Arzneimittel und Verfahren zu ihrer Herstellung |
NZ504324A (en) * | 1997-11-20 | 2002-02-01 | Teijin Ltd | Biphenylamidine derivatives and pharmaceutical compositions thereof; which can be useful as anticoagulant inhibitors, and thrombus or embolus preventing agents |
-
1998
- 1998-11-19 UA UA2000063535A patent/UA52797C2/uk unknown
- 1998-11-19 NZ NZ504407A patent/NZ504407A/en unknown
- 1998-11-19 ES ES98954747T patent/ES2218866T3/es not_active Expired - Lifetime
- 1998-11-19 PT PT98954747T patent/PT1043310E/pt unknown
- 1998-11-19 TR TR2000/01452T patent/TR200001452T2/xx unknown
- 1998-11-19 CA CA002310331A patent/CA2310331A1/en not_active Abandoned
- 1998-11-19 HU HU0100085A patent/HUP0100085A3/hu unknown
- 1998-11-19 EP EP98954747A patent/EP1043310B1/en not_active Expired - Lifetime
- 1998-11-19 US US09/554,799 patent/US6706745B1/en not_active Expired - Fee Related
- 1998-11-19 AU AU11740/99A patent/AU744567B2/en not_active Ceased
- 1998-11-19 TW TW087119208A patent/TW523504B/zh not_active IP Right Cessation
- 1998-11-19 PL PL98340658A patent/PL340658A1/xx not_active Application Discontinuation
- 1998-11-19 KR KR1020007005463A patent/KR100581506B1/ko not_active IP Right Cessation
- 1998-11-19 RU RU2000115947/04A patent/RU2197478C2/ru not_active IP Right Cessation
- 1998-11-19 ID IDW20000955A patent/ID24846A/id unknown
- 1998-11-19 IL IL13610098A patent/IL136100A/xx not_active IP Right Cessation
- 1998-11-19 CN CNB988132206A patent/CN1150162C/zh not_active Expired - Fee Related
- 1998-11-19 BR BR9814983-0A patent/BR9814983A/pt not_active Application Discontinuation
- 1998-11-19 EE EEP200000298A patent/EE04564B1/xx not_active IP Right Cessation
- 1998-11-19 DE DE69824450T patent/DE69824450T2/de not_active Expired - Fee Related
- 1998-11-19 SK SK761-2000A patent/SK7612000A3/sk unknown
- 1998-11-19 WO PCT/JP1998/005209 patent/WO1999026918A1/ja active IP Right Grant
- 1998-11-19 DK DK98954747T patent/DK1043310T3/da active
- 1998-11-19 AT AT98954747T patent/ATE268751T1/de not_active IP Right Cessation
-
2000
- 2000-05-15 IS IS5497A patent/IS5497A/is unknown
- 2000-05-16 HR HR20000304A patent/HRP20000304B1/xx not_active IP Right Cessation
- 2000-05-17 BG BG104447A patent/BG63536B1/bg unknown
- 2000-05-19 NO NO20002589A patent/NO20002589L/no unknown
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH04334351A (ja) * | 1991-01-24 | 1992-11-20 | Dr Karl Thomae Gmbh | ビフェニル誘導体、これらの化合物を含む製薬組成物及びそれらの調製法 |
JPH0650977A (ja) * | 1992-04-28 | 1994-02-25 | Dr Karl Thomae Gmbh | 標識フィブリノーゲンレセプター拮抗物質、その使用及びそれらの調製法 |
JPH101467A (ja) * | 1996-06-13 | 1998-01-06 | Banyu Pharmaceut Co Ltd | ビフェニルアミジン誘導体 |
Cited By (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1043311A4 (en) * | 1997-11-20 | 2001-01-24 | Teijin Ltd | BIPHENYLAMIDINE DERIVATIVES |
US6676968B1 (en) | 1999-01-28 | 2004-01-13 | Teijin Limited | Release-regulating preparations comprising biphenyldiamine derivatives |
WO2000044380A1 (fr) * | 1999-01-28 | 2000-08-03 | Teijin Limited | Preparations regulatrices de liberation |
AU773156B2 (en) * | 1999-01-28 | 2004-05-20 | Teijin Limited | Release-regulating preparations |
WO2000069811A1 (fr) * | 1999-05-17 | 2000-11-23 | Teijin Limited | Derives de cyanobiphenyle |
US6538137B1 (en) | 1999-05-17 | 2003-03-25 | Teijin Limited | Cyanobiphenyl derivatives |
WO2001056989A2 (en) * | 2000-02-01 | 2001-08-09 | Cor Therapeutics, Inc. | Inhibitors of factor xa |
WO2001056989A3 (en) * | 2000-02-01 | 2002-02-28 | Cor Therapeutics Inc | Inhibitors of factor xa |
US6949668B2 (en) | 2001-11-30 | 2005-09-27 | Teijin Limited | Process for producing 5-(3-cyanophenyl)-3-formylbenzoic acid compound |
EP2982668A2 (en) | 2002-12-03 | 2016-02-10 | Pharmacyclics LLC | 2-(2-hydroxybiphenyl-3-yl)-1h-benzoimidazole-5-carboxamidine derivatives as factor viia inhibitors for the treatment of thromboembolic disorders |
WO2007021032A1 (ja) | 2005-08-18 | 2007-02-22 | Teijin Pharma Limited | 正確な用量分割機能を有する製剤 |
WO2007021033A1 (ja) | 2005-08-18 | 2007-02-22 | Teijin Pharma Limited | 複数の薬物保持部位がある錠剤 |
EP3205337A1 (en) | 2005-08-18 | 2017-08-16 | Teijin Pharma Limited | Formulation having accurate dose-dividing function |
WO2007055427A1 (en) | 2005-11-14 | 2007-05-18 | Teijin Pharma Limited | Intraorally rapidly disintegrating tablet |
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US10882855B2 (en) | Substituted pyrrolidines as factor XIa inhibitors for the treatment thromboembolic diseases | |
WO1999026918A1 (fr) | Derives de biphenylamidine | |
JP4199309B2 (ja) | 新規アセトアミド誘導体およびプロテアーゼ阻害 | |
WO1999010316A1 (fr) | Derives de 3-amidinoaniline, inhibiteurs du facteur x de coagulation sanguine activee, et intermediaires de production de ces derives et de ces inhibiteurs | |
SA96160637B1 (ar) | مشتقات aroy1- piperidine | |
WO2003006670A2 (en) | 2-[5-(5-carbamimidoyl-1h-heteroaryl)-6-hydroxybiphenyl-3-yl]-succinic acid derivatives as factor viia inhibitors | |
JP2000178243A (ja) | ビフェニルアミジン誘導体 | |
WO1998046569A1 (fr) | Derives de benzene | |
US5665882A (en) | Pyridyl ethylation of lactams | |
WO1999054306A1 (fr) | Derives isoquinolinesulfonamide et medicaments integrant ces derives comme principe actif | |
JPH10195037A (ja) | フェノール誘導体 | |
KR20020004971A (ko) | 치환 프로린 유도체 및 이들을 함유하고 있는 의약 조성물 | |
EP0800516A1 (en) | FIBRINOGEN RECEPTOR ANTAGONISTS HAVING SUBSTITUTED (b)-AMINO ACID RESIDUES AND PHARMACEUTICAL COMPOSITIONS COMPRISING THE SAME | |
KR880001735B1 (ko) | 이소인돌 유도체 및 그것의 제조방법 | |
JP2524753B2 (ja) | フリルメチルチオエチルアミド誘導体 | |
WO2001030387A1 (fr) | Produits prophylactiques ou de traitement contre l'arythmie | |
LT3681B (en) | N-acyl-alpha-amino acid derivatives, method for producting thereof,pharmaceutical compositions and preparing them | |
JPS6134422B2 (ja) | ||
MXPA00004900A (en) | Biphenylamidine derivatives | |
MXPA00003419A (en) | PEPTIDE-CONTAINING&agr;-KETOAMIDE CYSTEINE AND SERINE PROTEASE INHIBITORS | |
BG63540B1 (bg) | Инхибитори на нiv-протеазата | |
JPH0162A (ja) | フェノキシ酢酸誘導体 | |
KR20000055994A (ko) | 피페리딘 작용기를 갖는 선택적 트롬빈 억제제 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
WWE | Wipo information: entry into national phase |
Ref document number: 98813220.6 Country of ref document: CN |
|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GD GE GH GM HR HU ID IL IS JP KE KG KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG US UZ VN YU ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): GH GM KE LS MW SD SZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) |
Free format text: (EXCEPT GD) |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
WWE | Wipo information: entry into national phase |
Ref document number: 11740/99 Country of ref document: AU |
|
WWE | Wipo information: entry into national phase |
Ref document number: 504407 Country of ref document: NZ |
|
WWE | Wipo information: entry into national phase |
Ref document number: 136100 Country of ref document: IL |
|
ENP | Entry into the national phase |
Ref document number: 2310331 Country of ref document: CA Ref document number: 2310331 Country of ref document: CA Kind code of ref document: A |
|
WWE | Wipo information: entry into national phase |
Ref document number: P20000304A Country of ref document: HR |
|
WWE | Wipo information: entry into national phase |
Ref document number: PV2000-1815 Country of ref document: CZ |
|
WWE | Wipo information: entry into national phase |
Ref document number: 1998954747 Country of ref document: EP Ref document number: 09554799 Country of ref document: US |
|
WWE | Wipo information: entry into national phase |
Ref document number: 7612000 Country of ref document: SK Ref document number: PA/a/2000/004900 Country of ref document: MX Ref document number: 1200000470 Country of ref document: VN Ref document number: 1020007005463 Country of ref document: KR |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2000/01452 Country of ref document: TR |
|
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
WWP | Wipo information: published in national office |
Ref document number: 1998954747 Country of ref document: EP |
|
WWP | Wipo information: published in national office |
Ref document number: PV2000-1815 Country of ref document: CZ |
|
WWP | Wipo information: published in national office |
Ref document number: 1020007005463 Country of ref document: KR |
|
WWG | Wipo information: grant in national office |
Ref document number: 11740/99 Country of ref document: AU |
|
WWG | Wipo information: grant in national office |
Ref document number: 1998954747 Country of ref document: EP |
|
WWG | Wipo information: grant in national office |
Ref document number: 1020007005463 Country of ref document: KR |